Difficult-to-treat and severe asthma in general practice: delivery and evaluation of an educational program
Tóm tắt
Asthma, a common yet complex airway disorder affecting about 11% of Australians, is well-controlled in only 54% of people with asthma. Those with difficult-to-treat and severe asthma are more likely to experience recurrent and potentially life-threatening exacerbations. It is therefore important that GPs can initiate a systematic approach for the management of patients with difficult-to-treat asthma to identify those whose condition may improve by addressing contributory factors and those who require specialist input. We therefore aimed to develop and deliver an educational program for GPs on the systematic management of patients with difficult-to-treat and severe asthma and evaluate the effectiveness of this program. We developed an educational program on the management of difficult-to-treat and severe asthma in primary care that was delivered to GPs and other health professionals between January and June 2018. We evaluated the effectiveness of the program using a retrospective pre-test with post-survey, administered to GPs directly after program participation. Over 1000 general practice health professionals participated in the educational program, including 890 GPs of whom 226 (25%) completed the survey. Following program participation, a greater proportion of GPs identified factors they would assess in managing a patient with poor asthma control, particularly for considering the risk of future adverse outcomes (+ 51%), changes in lifestyle (+ 38%), and self-management strategies (+ 35%). GPs indicated a greater awareness of the biologic therapies that specialists could consider prescribing to their patients with severe asthma (+ 75%), of the requirements for a patient to be prescribed a biologic therapy (+ 73%) and that patients with different phenotypic characteristics can respond differently to standard therapy (+ 67%). The proportion of GPs who would refer appropriate patients to a specialist also significantly increased. This study suggests that an evidence-based educational program can improve GP knowledge, confidence and intended practice in managing patients with difficult-to-treat and severe asthma.
Tài liệu tham khảo
National Health Survey: First Results, Australia 2017–18. 2018. http://www.abs.gov.au/ausstats/[email protected]/mf/4364.0.55.001. Accessed 6 Nov 2018.
Reddel HK, Sawyer SM, Everett PW, Flood PV, Peters MJ. Asthma control in Australia: a cross-sectional web-based survey in a nationally representative population. Med J Aust. 2015;202(9):492–7.
McDonald VM, Maltby S, Reddel HK, King GG, Wark PA, Smith L, Upham JW, James AL, Marks GB, Gibson PG. Severe asthma: current management, targeted therapies and future directions-a roundtable report. Respirology. 2017;22(1):53–60.
Australian Asthma Handbook, Version 1.3. http://www.asthmahandbook.org.au/. Accessed 31 Jan 2019.
Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2018. https://ginasthma.org/wp-content/uploads/2019/01/2018-GINA.pdf. Accessed 22 Oct 2018.
Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, Adcock IM, Bateman ED, Bel EH, Bleecker ER, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–73.
Israel E, Reddel HK. Severe and difficult-to-treat asthma in adults. N Engl J Med. 2017;377(10):965–76.
Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180(1):59–99.
Taylor DR, Bateman ED, Boulet L-P, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, de Jongste JC, et al. A new perspective on concepts of asthma severity and control. Eur Respir J. 2008;32(3):545–54.
Drazen JM, Harrington D. New biologics for asthma. N Engl J Med. 2018;378(26):2533–4.
Upham JW, Chung LP. Optimising treatment for severe asthma. Med J Aust. 2018;209(2 suppl):S22–S7.
Pharmaceutical Benefits Scheme. Mepolizumab. http://www.pbs.gov.au/medicine/item/10980X-10996R-11003D-11014Q. Accessed 15 Nov 2018.
Pharmaceutical Benefits Scheme. Omalizumab. http://www.pbs.gov.au/medicine/item/10110D-10118M-10956P-10967F. Accessed 15 Nov 2018.
Pharmaceutical Benefits Scheme. Benralizumab. http://www.pbs.gov.au/medicine/item/11504L-11523L-11529T-11549W. Accessed 4 Dec 2018.
MedicineInsight. www.medicineinsight.org.au. Accessed 11 Oct 2018.
Chidwick K, Kiss D, Gray R, Yoo J, Aufgang M, Zekry A. Insights into the management of chronic hepatitis C. Aust J Gen Pract. 2018;47:639–45.
González-Chica DA, Vanlint S, Hoon E, Stocks N. Epidemiology of arthritis, chronic back pain, gout, osteoporosis, spondyloarthropathies and rheumatoid arthritis among 1.5 million patients in Australian general practice: NPS MedicineWise MedicineInsight dataset. BMC Musculoskelet Disord. 2018;19(1):20.
NPS MedicineWise, General Practice Insights Report July 2016–June 2017: A working paper. https://www.nps.org.au/medicine-insight/using-medicineinsight-data. Accessed 14 Feb 2019.
The Second Australian Atlas of Healthcare Variation 2017. https://www.safetyandquality.gov.au/atlas/atlas-2017/. Accessed 10 Oct 2018.
O'Brien MA, Rogers S, Jamtvedt G, Oxman AD, Odgaard-Jensen J, Kristoffersen DT, Forsetlund L, Bainbridge D, Freemantle N, Davis D, et al. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2007;4:CD000409.
Soumerai SB, Avorn J. Principles of educational outreach ('academic detailing') to improve clinical decision making. JAMA. 1990;263(4):549–56.
Bhanji F, Gottesman R, de Grave W, Steinert Y, Winer LR. The retrospective pre–post: a practical method to evaluate learning from an educational program. Acad Emerg Med. 2012;19(2):189–94.
Davis GA. Using a retrospective pre-post questionnaire to determine program impact. J Ext. 2003;41(4). https://www.joe.org/joe/2003august/tt4.php. Accessed 11 July 2019.
Klatt J, Taylor-Powell E. Synthesis of literature relative to the retrospective pretest design. Toronto: Presentation to the 2005 Joint CES/AEA Conference; 2005.
Lamb T. The retrospective pretest: an imperfect but useful tool. Eval Exchange. 2005;11(2):18–9.
Pratt CC, McGuigan WM, Katzev AR. Measuring program outcomes: using retrospective pretest methodology. Am J Eval. 2000;21(3):341–9.
Rockwell SK, Kohn H. Post-then-pre evaluation. J Ext. 1989;27(2):19–21.
Adedokun OA, Burgess WD. Analysis of paired dichotomous data: a gentle introduction to the McNemar test in SPSS. J Multidiscip Eval. 2011;8(17):125–31.
Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, de Jongste JC, et al. A new perspective on concepts of asthma severity and control. Eur Respir J. 2008;32(3):545–54.
Aaron SD, Vandemheen KL, FitzGerald JM, Ainslie M, Gupta S, Lemiere C, Field SK, McIvor RA, Hernandez P, Mayers I, et al. Reevaluation of diagnosis in adults with physician-diagnosed asthma. JAMA. 2017;317(3):269–79.
Lee J, Tay TR, Radhakrishna N, Hore-Lacy F, Mackay A, Hoy R, Dabscheck E, O'Hehir R, Hew M. Nonadherence in the era of severe asthma biologics and thermoplasty. Eur Respir J. 2018;51(4):1701836.
Sanchis J, Gich I, Pedersen S. Systematic review of errors in inhaler use: has patient technique improved over time? Chest. 2016;150(2):394–406.
Radhakrishna N, Tay TR, Hore-Lacy F, Stirling R, Hoy R, Dabscheck E, Hew M. Validated questionnaires heighten detection of difficult asthma comorbidities. J Asthma. 2017;54(3):294–9.
Tay TR, Lee JW-Y, Hew M. Diagnosis of severe asthma. Med J Aust. 2018;209(2 Suppl):S3–S10.
Allen JM, Nimon K. Retrospective pretest: a practical technique for professional development evaluation. J Ind Teach Educ. 2007;44(3):27–42.
Hill LG, Betz DL. Revisiting the retrospective pretest. Am J Eval. 2005;26(4):501–17.
Lam TC, Bengo P. A comparison of three retrospective self-reporting methods of measuring change in instructional practice. Am J Eval. 2003;24(1):65–80.
Nimon K, Zigarmi D, Allen J. Measures of program effectiveness based on retrospective pretest data: are all created equal? Am J Eval. 2011;32(1):8–28.
Parkinson A, Jorm L, Douglas KA, Gee A, Sargent GM, Lujic S, McRae IS. Recruiting general practitioners for surveys: reflections on the difficulties and some lessons learned. Aust J Prim Health. 2015;21(2):254–8.
Crouch S, Robinson P, Pitts M. A comparison of general practitioner response rates to electronic and postal surveys in the setting of the national STI prevention program. Aust N Z J Public Health. 2011;35(2):187–9.